Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This prospective study will investigate the characteristics of mRCC patients at time of CR in
comparison with mRCC patients non on CR treated with Sunitinib, in order to provide some
answers/ refection leads to the following questions :
Can we identify blood specificity at time of CR vs non on CR? Shall we distinguish CR with
sunitinib alone from combined CR (sunitinib with local treatment), while in clinical report
these 2 cohorts present similar time to recurrence (ALBIGES, ASCO 2010)? Can we identify
potential predictive serum biomarkers of recurrence? (With the aim of isolating blood
biomarker that can help on treatment discontinuation decision?)